patent expiration

ILEVRO (nepafenac) Harrow eye Patent: 7,947,295 Expiration: Jun 8, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
Source

Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. It is available from one supplier. There are nine…
Source

Annual Drug Patent Expirations for ZONTIVITY Zontivity is a drug marketed by Xspire Pharma and is included in one NDA. There are two patents protecting this drug. ZONTIVITY drug price…
Source

Annual Drug Patent Expirations for ZONTIVITY Zontivity is a drug marketed by Xspire Pharma and is included in one NDA. There are two patents protecting this drug. ZONTIVITY drug price…
Source

Annual Drug Patent Expirations for NUVIGIL Nuvigil is a drug marketed by Cephalon and is included in one NDA. It is available from seven suppliers. There are two patents protecting…
Source

Annual Drug Patent Expirations for PROVIGIL Provigil is a drug marketed by Cephalon and is included in one NDA. It is available from three suppliers. There is one patent protecting…
Source

ACULAR LS (ketorolac tromethamine) Abbvie Patent: 9,216,167 Expiration: May 28, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
Source

Annual Drug Patent Expirations for ACULAR+LS Acular Ls is a drug marketed by Abbvie and is included in one NDA. It is available from three suppliers. There are eight patents…
Source

Annual Drug Patent Expirations for ENTRESTO Entresto is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from two suppliers. There are eight…
Source

Annual Drug Patent Expirations for OXAYDO Oxaydo is a drug marketed by Zyla and is included in one NDA. It is available from one supplier. There are two patents protecting…
Source